Vetnuus | November 2024 13 “This situation is critical - there is little Trilostane left in the country, and without it, many animals will face severe suffering,” said Dr Oosthuyse. “It is incomprehensible that we are now again encountering barriers for a medication that SAHPRA has been aware of and allowed for years despite constructive engagement on the subject. V-Tech has now approached the Minister of Health to intervene.” In light of these ongoing challenges, V-Tech remains committed to supporting the veterinary community. The company continues to advocate for the urgent resolution of both the Yohimbine and Trilostane disputes and the establishment of an expert forum to advise SAHPRA on the unique challenges faced by veterinarians who require access to specialised medicines. v Article Email: assistant@sava.co.za ADVERTISE IN VETNEWS MAGAZINE We, the members of the Association, resolve at all times: • To honour our profession and the Veterinary Oath • To maintain and uphold high professional and scientific standards • To use our professional knowledge, skills and resources to protect and promote the health and welfare of animals and humans • To further the status and image of the veterinarian and to foster and enrich veterinary science • To promote the interests of our Association and fellowship amongst its members. Ons, die lede van die Vereniging, onderneem om te alle tye: • Ons professie in ere te hou en die Eed na te kom • ‘n Hoë professionele en wetenskaplike peil te handhaaf en te onderhou • Ons professionele kennis, vaardigheid en hulpbronne aan te wend ter beskerming en bevordering van die gesondheid en welsyn van dier en mens • Die status en beeld van die veearts te bevorder en die veeartsenykunde te verryk • Die belange van ons Vereniging en die genootskap tussen sy lede te bevorder. CREDO
RkJQdWJsaXNoZXIy OTc5MDU=